The BaseLaunch accelerator supports carefully selected ventures over the course of 15 months and runs in two phases. It provides non-dilutive funding, no strings attached access to its Healthcare Partners, knowledge from highly experienced advisors, as well as a state-of-the-art infrastructure. Furthermore, Baselaunch embeds the ventures deeply within the Basel region, one of Europe’s finest biotech ecosystem. Baselaunch is backed by five industry leaders — Johnson & Johnson Innovation, Novartis Venture Fund, Pfizer, Roche and Roivant Sciences — as well as by other public and private partners.
BaseLaunch was launched in 2017 as an initiative of BaselArea.swiss, the innovation and economic promotion agency for the region of Basel, which oversees and manages the operations of BaseLaunch. Through its extensive network of decision-makers, innovators and experts, BaselArea.swiss supports entrepreneurs and companies from abroad with the successful implementation of innovation and business ventures in the Basel region.
The next cycle starts in September 2018 and runs in two phases through December 2019. Applications for the 2019 cycle can be submitted now.